Carotid and cerebrovascular disease in symptomatic patients with type 2 diabetes: assessment of prevalence and plaque morphology by dual-source computed tomography angiography

<p>Abstract</p> <p>Background</p> <p>Plaque morphology directly correlates with risk of embolism and the recently developed dual-source computed tomography angiography (DSCTA) may help to detect plaques more precisely. The aim of our study was to evaluate the prevalence and morphology of carotid and cerebrovascular atherosclerotic plaques in patients with symptomatic type 2 diabetes mellitus (DM) by DSCTA.</p> <p>Methods</p> <p>From July 2009 to August 2010, DSCTA was prospectively performed in 125 consecutive patients with symptomatic type 2 DM. We retrospectively analyzed plaque type, distribution, and extensive and obstructive natures were determined for each segment for all patients.</p> <p>Results</p> <p>Atherosclerotic plaques were detected in 114 (91.2%) patients. Relatively more noncalcified (45%) and calcified (39%) plaques and less mixed (16%) plaques were observed (p < 0.001). Noncalcified plaques were found mainly in the intracranial arteries (81.8%), mixed plaques in the intracranial arteries (25.2%) and intracranial internal carotid artery (ICA) (56.1%). Calcified plaques were found mainly in the intracranial ICA (65.9%) and extracranial arteries (28.2%) (for all, p < 0.001). Extension of plaques from the 1^stto 5^thsegments was observed in 67 (58.8%) patients and from the 6^thto 10^thsegments in 35 (30.7%) patients. The most common site of all detected plaques was the cavernous segment. Regarding stenosis, there were significantly more nonobstructive than obstructive stenosis (91% vs. 9%, p < 0.001).</p> <p>Conclusion</p> <p>DSCTA detected a high prevalence of plaques in patients with symptomatic type 2 DM. A relatively high proportion of plaques were noncalcified, as well as with nonobstructive stenosis. The distribution of plaques was extensive, with the cavernous portion of ICA being the most common site.</p

Global analysis of measured and unmeasured hadronic two-body weak decays of antitriplet charmed baryons

A large amount of data on hadronic two body weak decays of anti-triplet charmed baryons $T_{c\bar 3}$ to an octet baryon $T_8$ and an octet or singlet pseudoscalar meson $P$, $T_{c \bar 3} \to T_8 P$, have been measured. The SU(3) flavor symmetry has been applied to study these decays to obtain insights about weak interactions for charm physics. However not all such decays needed to determine the SU(3) irreducible amplitudes have been measured forbidding a complete global analysis. Previously, it has been shown that data from measured decays can be used to do a global fit to determine all except one parity violating and one parity conserving amplitudes of the relevant SU(3) irreducible amplitudes causing 8 hadronic two body weak decay channels involving $\Xi^0_c$ to $\eta$ or $\eta'$ transitions undetermined. It is important to obtain information about these decays in order to guide experimental searches. In this work using newly measured decay modes by BESIII and Belle in 2022, we carry out a global analysis and parameterize the unknown amplitudes to provide the ranges for the branching ratios of the 8 undetermined decays. Our results indicate that the SU(3) flavor symmetry can explain the measured data exceptionally well, with a remarkable minimal $\chi^2/d.o.f.$ of 1.21 and predict 80 observables in 45 decays for future experimental data to test. We then vary the unknown SU(3) amplitudes to obtain the allowed range of branching ratios for the 8 undetermined decays. We find that some of them are within reach of near future experimental capabilities. We urge our experimental colleagues to carry out related searches.Comment: 9pages, 2 figures, 3 table

Characteristics of coronary artery disease in symptomatic type 2 diabetic patients: evaluation with CT angiography

<p>Abstract</p> <p>Background</p> <p>Coronary artery disease (CAD) is a common and severe complication of type 2 diabetes mellitus (DM). The aim of this study is to identify the features of CAD in diabetic patients using coronary CT angiography (CTA).</p> <p>Methods</p> <p>From 1 July 2009 to 20 March 2010, 113 consecutive patients (70 men, 43 women; mean age, 68 ± 10 years) with type 2 DM were found to have coronary plaques on coronary CTA. Their CTA data were reviewed, and extent, distribution and types of plaques and luminal narrowing were evaluated and compared between different sexes.</p> <p>Results</p> <p>In total, 287 coronary vessels (2.5 ± 1.1 per patient) and 470 segments (4.2 ± 2.8 per patient) were found to have plaques, respectively. Multi-vessel disease was more common than single vessel disease (<it>p </it>< 0.001), and the left anterior descending (LAD) artery (35.8%) and its proximal segment (19.1%) were most frequently involved (all <it>p </it>< 0.001). Calcified plaques (48.8%) were the most common type (<it>p </it>< 0.001) followed by mixed plaques (38.1%). Regarding the different degrees of stenosis, mild narrowing (36.9%) was most common (<it>p </it>< 0.001); however, a significant difference was not observed between non-obstructive and obstructive stenosis (50.4% vs. 49.6%, <it>p </it>= 0.855). Extent of CAD, types of plaques and luminal narrowing were not significantly different between male and female diabetic patients.</p> <p>Conclusions</p> <p>Coronary CTA depicted a high plaque burden in patients with type 2 DM. Plaques, which were mainly calcified, were more frequently detected in the proximal segment of the LAD artery, and increased attention should be paid to the significant prevalence of obstructive stenosis. In addition, DM reduced the sex differential in CT findings of CAD.</p

Application of RetCamⅡ in the screening of neonatal fundus disease

AIM: To investigate the safe and reliable examination method for neonatal fundus screening.<p>METHODS: Fundus information of 2 836 neonates performed by RetCamⅡ in our hospital from January 1, 2012 to December 31, 2012 were retrospectively analyzed, including 1 625 cases(57.30%)of premature infants which were first examined 1-4 weeks after birth and 1 211 cases(42.70%)of term infants which were first examined within 4 weeks after birth.<p>RESULTS: Totally 454 cases of abnormalfundus were found, including 207 cases(12.74%)of retinopathy of prematurity(ROP), ROPⅠ in 118 cases(57%), ROPⅡ in 58 cases(28.02%), ROPⅢ in 23 cases(11.11%), ROPⅣ in 8 cases(3.86%), no case of ROPV. A total of 247(20.40%)term infants had abnormal fundus, of which 68 cases(27.53%)were developmental or hereditary disease, retinoblastoma in 1 case(0.40%), retinal hemorrhage in 102 cases(41.30%), retinal exudative changes in 68 cases(27.53%), optic atrophy in 5 cases(2.02%)and optic disc edema in 3 cases(1.21%).<p>CONCLUSION: Neonatal fundus diseases were so various and harmful that early screening should be attended to. Premature infants and term infants with high risk are treated as focus group of fundus screening and RetCamII examination is safe and effective

Dark photon kinetic mixing effects for the CDF W-mass measurement

A new $U(1)_X$ gauge boson $X$ primarily interacting with a dark sector can have renormalizable kinetic mixing with the standard model (SM) $U(1)_Y$ gauge boson $Y$. This mixing besides introduces interactions of dark photon and dark sector with SM particles, it also modifies interactions among SM particles. The modified interactions can be casted into the oblique $S$, $T$ and $U$ parameters. We find that with the dark photon mass larger than the $Z$ boson mass, the kinetic mixing effects can reduce the tension of the W mass excess problem reported recently by CDF from $7\sigma$ deviation to within $3 \sigma$ compared with theory prediction. If there is non-abelian kinetic mixing between $U(1)_X$ and $SU(2)_L$ gauge bosons, in simple renormalizable models of this type a triplet Higgs is required to generate the mixing. We find that this triplet with a vacuum expectation value of order 5 GeV can naturally explain the W mass excess.Comment: 10 pages, add new ref and no change for conclusio

Peripheral Leukocytapheresis Attenuates Acute Lung Injury Induced by Lipopolysaccharide In Vivo

The mortality of acute lung injury and acute respiratory distress syndrome (ALI/ARDS) remains high and efforts for prevention and treatments have shown little improvement over the past decades. The present study investigated the efficacy and mechanism of leukocytapheresis (LCAP) to partially eliminate peripheral neutrophils and attenuate lipopolysaccharide (LPS)-induced lung injury in dogs. A total of 24 healthy male mongrel dogs were enrolled and randomly divided into LPS, LCAP and LCAP-sham groups. All animals were injected with LPS to induce endotoxemia. The serum levels of leucocytes, neutrophil elastase, arterial blood gas, nuclear factor-kappa B (NF-κB) subunit p65 in lung tissues were measured. The histopathology and parenchyma apoptosis of lung tissues were examined. We found that 7, 3, and 7 animals in the LPS, LCAP, and sham-LCAP groups, respectively, developed ALI 36 h after LPS infusion. The levels of NF-κB p65 in lung tissue, neutrophils and elastase in blood, decreased significantly following LCAP. LCAP also alleviated apoptosis, and NF-κB p65 in lung tissues. Collectively, our results show that partial removal of leucocytes from peripheral blood decreases elastase level in serum. This, in turn, attenuates lung injuries and may potentially decrease the incidence of ALI